Results 91 to 100 of about 34,678,823 (254)
Rogue traders versus value-at-risk and expected shortfall [PDF]
We show that, in a Black and Scholes market, value at risk and ex- pected shortfall are irrelevant in limiting traders excessive tail-risk seeking behaviour as modelled via Kahneman and Tversky’s S-shaped utility. To have effective constraints one can
Brigo, D, Armstrong, John
core
Design and analysis strategies for robust microbiome ageing research
The gut microbiome changes with age and associates with age‐related morbidity and mortality, establishing it as a potential biomarker and intervention target for ageing. Realising this potential requires methodological rigour, yet distinguishing biological signals from methodological artefacts remains challenging across cohorts. This review provides an
Mark Olenik +5 more
wiley +1 more source
Reconstructing enzyme evolution by protein engineering
Natural enzyme evolution can be retraced by protein engineering methods such as directed evolution, rational design, and ancestral sequence reconstruction. These approaches reveal how enzymes emerged from ligand‐binding scaffolds, developed varying substrate preferences, formed oligomeric complexes, adapted to environmental changes, and evolved novel ...
Lukas Drexler +2 more
wiley +1 more source
Project DINGGIN: Empowering Communities through Risk‐Based and Inclusive Cash Transfer in Disaster‐Prone Areas in Bangladesh and Philippines [PDF]
Disaster-prone communities in Albay, Philippines and Bhola, Bangladesh, face recurring typhoons, cyclones, and floods that simultaneously destroy homes, disrupt livelihoods, and threaten food security.
M. Canete, Rhinadel +2 more
core +1 more source
Microbiome‐blood–brain barrier interactions in aging — mechanisms and therapeutic potential
Aging reshapes the gut microbiome (↓SCFA‐producing commensals; ↑pro‐inflammatory outputs), shifting circulating metabolites (↓SCFAs; ↑LPS, ↑TMAO, ↑PAA) that act at the BBB to increase nonspecific transcytosis, alter transport, and promote astrocyte reactivity, heightening brain vulnerability.
Daniel Cuervo‐Zanatta +3 more
wiley +1 more source
Structure‐forward targeting of claudins with synthetic binders
Claudins form the paracellular barriers between epithelial and endothelial tissues at tight junctions and are targets for molecular binders with the goal of modulating barrier permeability. Claudin‐binding molecules are relevant in drug delivery or in altering claudin interactions with disease‐causing proteins.
Alex J. Vecchio
wiley +1 more source
A ranking system for veterinary medicinal products and medicated feed products has been developed as a tool to be applied in a risk-based approach to the residue testing programme for foods of animal origin in the National Residue Control ...
Food Safety Authority of Ireland (FSAI)
core
Engineering peptides into antibodies—opportunities and strategies for therapeutic innovation
Peptides and antibodies occupy complementary therapeutic niches. Peptides recognize difficult targets in a compact format, while antibodies add specificity, long half‐life, and effector functions. This review examines strategies that merge both modalities—peptide grafting into loops, terminal and Fc fusions, and bioconjugation—highlighting how ...
Jinling Wang +2 more
wiley +1 more source
BackgroundConducting clinical trials (CTs) with children presents several challenges. A major challenge is the need to enrol participants at multiple sites across different jurisdictions. Regardless of whether the trials involve children, adults, or both,
Breanne Stewart +28 more
doaj +1 more source
Frequently Asked Questions Related to the Commission on Evidence-Based Policymaking's Report
List of frequently-asked questions regarding the final report of the U.S. Commission on Evidence-Based Policymaking with answers and clarifications. Questions are broken into five topics: general, National Secure Data Service (NSDS), privacy, access ...
United States. Commission on Evidence-Based Policymaking.
core

